创金合信全球医药生物股票发起(QDII)A(018155)持股变动
| 序号 |
股票代码 |
股票简称 |
变动数量(股) |
变动市值(元) |
变动类型 |
| 1 |
BIIB |
生化基因 |
6,734.00 |
9,909,505.61 |
新增 |
| 2 |
DNLI |
Denali Therapeutics Inc |
55,296.00 |
9,686,551.34 |
新增 |
| 3 |
IONS |
Ionis Pharmaceuticals Inc |
13,376.00 |
7,223,525.03 |
新增 |
| 4 |
KRYS |
Krystal Biotech Inc |
2,800.00 |
7,087,940.17 |
新增 |
| 5 |
CYTK |
Cytokinetics Inc |
12,208.00 |
7,083,332.73 |
新增 |
| 6 |
ORIC |
Oric Pharmaceuticals Inc |
96,000.00 |
7,081,156.51 |
新增 |
| 7 |
NAMS |
NewAmsterdam Pharma Co NV |
6,489.00 |
1,886,994.39 |
仓增 |
| 8 |
PTGX |
Protagonist Therapeutics Inc |
0.00 |
1,394,228.23 |
持有 |
| 9 |
COGT |
Cogent Biosciences Inc |
3,157.00 |
745,421.31 |
仓增 |
| 10 |
EWTX |
Edgewise Therapeutics Inc |
-20,000.00 |
-1,886,887.42 |
减仓 |
微信公众号
证券之星APP
基本资料
